• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
LCB
Click for more information
0.00% 65.0¢

Logan Community Financial Services Limited

watchlist Created with Sketch. Add to my watchlist

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
LCB
Ann:Annual Report (Price Sensitive) 		16/09/24 0 123
16/09/24 Last post  NSX News Comments Created with Sketch.  0  Views Created with Sketch.  123 
LCB
Ann:Trading Halt (Price Sensitive) 		16/09/24 0 107
16/09/24 Last post  NSX News Comments Created with Sketch.  0  Views Created with Sketch.  107 
LCB
Ann:Notice of Final Director Interest 		13/06/24 0 202
13/06/24 Last post  NSX News Comments Created with Sketch.  0  Views Created with Sketch.  202 
LCB
Ann:Director Resignation 		04/06/24 0 272
04/06/24 Last post  NSX News Comments Created with Sketch.  0  Views Created with Sketch.  272 
LCB
Ann:Special Dividend Notification (Price Sensitive) 		23/04/24 0 301
23/04/24 Last post  NSX News Comments Created with Sketch.  0  Views Created with Sketch.  301 
LCB
Ann:Director Appointment - Leeanne Braund 		19/04/24 0 280
19/04/24 Last post  NSX News Comments Created with Sketch.  0  Views Created with Sketch.  280 
LCB
Ann:Initial Notice of Director Interest's - Leeanne Braund 		19/04/24 0 268
19/04/24 Last post  NSX News Comments Created with Sketch.  0  Views Created with Sketch.  268 
LCB
Ann:Annexure 3a - Half Yearly - 31 December 2023 (Price Sensitive) 		14/03/24 0 200
14/03/24 Last post  NSX News Comments Created with Sketch.  0  Views Created with Sketch.  200 

See All Discussions arrow Created with Sketch.

Timeline

Annual Report (Price Sensitive)
16 Sep 13:49
 
Trading Halt (Price Sensitive)
16 Sep 10:05
 
Notice of Final Director Interest
13 Jun 14:25
 
Director Resignation
04 Jun 15:15
 
Special Dividend Notification (Price Sensitive)
23 Apr 13:15
 
Initial Notice of Director Interest's - Leeanne Braund
19 Apr 08:54
 
View More arrow Created with Sketch.

Featured News

NEWS Major shallow copper-silver discovery at Junction Prospect confirmed with high-grade intercepts
right-arrow Created with Sketch.
NEWS High-grade copper-gold at Mt Isa North—grab samples hit up to 30% Cu and more, with drilling set to begin
right-arrow Created with Sketch.
NEWS Drilling kicks off at Goldsworthy East—30 holes planned to unlock major westward potential
right-arrow Created with Sketch.
NEWS Shallow high-grade gold hits at Star of Mangaroon and Popeye—see the latest drill results and what’s next
right-arrow Created with Sketch.
NEWS Solar building envelope order secured for iconic WA project—discover more about this groundbreaking solar solution
right-arrow Created with Sketch.
NEWS High-grade drilling results extend Cowboy State Mine—172.4m @ 3,716 ppm TREO confirmed
right-arrow Created with Sketch.
 (live)
Last
65.0¢ 		Change
0.000(0.00%) 		Mkt cap ! n/a
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
LCB (NSXA) Chart

Top Stories

Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t

Maximus Resources (ASX:MXR) has unveiled its latest drilling assay results at Eagles Nest, hitting gold downhole multiple assets.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
PainChek close to finding out if FDA approves its flagship app for use in dementia care PainChek (ASX:PCK) has updated the market on the progress of its De Novo submission to the US FDA for its flagship app in aged care settings.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.

Featured News

NEWS High-grade drilling results extend Cowboy State Mine—172.4m @ 3,716 ppm TREO confirmed
right-arrow Created with Sketch.
NEWS Exceptional rock chip assays at Pearl Copper Project—up to 930 g/t Ag and 10.05% Cu in Arizona
right-arrow Created with Sketch.
NEWS High-grade antimony mineralization confirmed at Ricciardo with potential 1km strike length
right-arrow Created with Sketch.
NEWS Significant copper and TREO results from West Arunta Project indicate a substantial multi-million tonne copper resource, with mineralisation starting from surface
right-arrow Created with Sketch.
NEWS Strong copper-gold surface results confirmed at Fortuna Project, revealing significant mineralisation potential
right-arrow Created with Sketch.
NEWS Drilling at May Queen intersects altered porphyritic rocks and copper sulphides, supporting a large-scale copper-gold system
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.